HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Market Intelligence

Set Alert for Market Intelligence

An Expert’s Guide To Switching In Germany, Part 2: Improving The Reclassification Process

In Part 2 of this exclusive interview, Elmar Kroth, scientific director of the German Medicines Manufacturers´ Association, the BAH, tells HBW Insight what the association is doing to improve the prescription-to-OTC switch process in Germany. 
Market Intelligence Prescription To Otc Switch

How Pfizer Achieved 'Switch Success' With Viagra and Nexium

Pfizer secured two of the biggest prescription-to-OTC switches in recent years with the reclassification of Viagra and Nexium. Michelle Riddalls, Pfizer's director of regulatory affairs in Europe, offers her advice to firms looking to emulate this 'switch success'.

Prescription To Otc Switch Market Intelligence

Use Real World Evidence To Drive Innovation, IQVIA Advises

Market researcher IQVIA explains how 'real world evidence' can help generate new health claims for OTC products and pre-market consumer data for innovative prescription-to-OTC switches.
Market Intelligence Consumer

An Expert’s Guide To Switching In Germany, Part 1: Navigating The Reclassification Process

Elmar Kroth, scientific director of the German Medicines Manufacturers´ Association, the BAH, talks exclusively to HBW Insight about prescription-to-OTC switching in Germany and the association’s efforts to improve this process.

Market Intelligence Consumer

Petite ‘N Pretty Makeup For Kids As Young As Four? Opportunity Could Be Worth The Static

The Los Angeles-area startup is taking heat for its name, messaging and apparent target audience, consisting of kids as young as four or five, particularly those with an Instagram following. The brand’s critics acknowledge that child influencers are an undeniable reality, and as Petite ‘N Pretty attests, they’re both highly effective and affordable.

Business Strategies Advertising, Marketing & Sales

Unilever Names New CEO; Sexy Hair’s $2.3m ‘Sulfate-Free’ Settlement; More Cosmetics News In Brief

Henkel’s Sexy Hair Concepts and Ulta will settle with plaintiffs over alleged “sulfate-free” deception, to the tune of $2.3m; Unilever’s Dermalogica is suing Target for unauthorized selling of diverted products. More cosmetics news in brief.

Legal Issues Leadership
See All
UsernamePublicRestriction

Register